New scientific article published in Frontiers: Viral Infections, the Microbiome, and Probiotics

Lallemand Health Solutions’ R&D Director for Microbiome Program and Bioprocess and Galenic Center, Sylvie Binda, together with IPA colleagues have cowritten a…

Lallemand Health Solutions’ Research Director chosen for External Advisory Board at the University of Florida

Thomas A. Tompkins, Ph.D., Research Director at the Rosell® Institute from Microbiome and Probiotics by Lallemand, is proud to be joining the…

Promising North American Clinical Study on the Use of SIMBA Capsule to Detect a Dietary Intervention in the Small Intestine

Lallemand Health Solutions and Nimble Science are proud to officially kick-off the first North American clinical study of Nimble’ Small Intestine Microbiome…

A long-term partnership towards a new probiotic certification program based on innovative biotechnology

Lallemand Health Solutions and the Natural Health Product Research Alliance (NHP RA) affiliated with the University of Guelph, both Canadian entities, are…

Expand the synergistic effect of S. boulardii from digestive health to immunity

Make the difference and expand the synergistic effect of S. boulardii by combining the probiotic yeast with powerful yeast-based ingredients and documented…

Open access review on probiotics effects on microbiota-gut-brain axis in early-life stress and neuropsychiatric disorders

Discover the latest open access review on “The effects of psychobiotics on the microbiota-gut-brain axis in early-life stress and neuropsychiatric disorders” recently…

New Canadian health claims leading to innovative probiotic applications

Lallemand Health Solutions has gained new indications for its documented Expert’Biotic IBacilluS+ (a combination of probiotic strain Enterococcus faecium Rosell®-26 and Bacillus…

New results showing LACIDOFIL® protects from early-life stress consequences

Infantile stress predisposes individuals to higher anxiety in adulthood. In a new in vivo study, early intake of Lacidofil® (Lallemand Health Solutions…

CEREBIOME® capacity to increase brain-derived neurotrophic factor levels translate from preclinical to clinical study

A new post-hoc analysis confirmed in humans that CEREBIOME® can increase significantly brain-derived neurotrophic factor (BDNF) serum levels as observed several years…

The first psychobiotic in Brazil

Apsen, located in São Paulo, Brazil, in partnership with Lallemand Health Solutions, are launching in September the first probiotic formulation for the…